Navigation Links
Cancer Game Changers: Genomics, Smarter Medicine, Care Coordination Comprise Medco's Advanced Oncology Solutions™
Date:7/19/2011

FRANKLIN LAKES, N.J., July 19, 2011 /PRNewswire/ -- Oncology treatments are not what they were a decade ago.  Drugs that target specific molecular pathways in a cancer cell are being added to or replacing once standard therapies, requiring a new model of patient care.  Medco Health Solutions, Inc. (NYSE: MHS) today announced new offerings within its Advanced Oncology Solutions™, that include treatment pathways decision support with embedded pharmacogenomic testing and nutrition recommendations for cancer patients.

(Logo: http://photos.prnewswire.com/prnh/20100609/MEDCOLOGO)

Treatment Pathway Connections is the newest component in Medco's Advanced Oncology Solution's platform, which coordinates care among physicians, pharmacists, case managers and payers, and informs them of evidence-based protocols before and during treatment.  eviti®, a web-based oncology decision-support program developed by ITA Partners, Inc.®, will power the treatment plan decision-support function of the platform.

"Through eviti, our treatment pathway program is able to align quality care with reimbursement, reduce complexity, provide transparency and improve workflows for physicians and payers," said Jeff Ulanet, vice president oncology.  "Our goal is to reduce the gaps in care that negatively impact patient outcomes and can lead to unnecessary treatment costs."

Medco is the first PBM to offer this independent, comprehensive oncology decision support approach that contains more than 1,000 evidence based treatment regimens for more than 120 cancer types, displaying efficacy, costs, toxicity and compliance with the patient's plan language – all at the moment of prescribing.  ITA Partners, which employs a team of oncologists, oncology nurses, insurance professionals, actuaries, software designers and engineers has specialized in oncology de
'/>"/>

SOURCE Medco Health Solutions, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. Novel Technology Breaks Through Cancer Pain
8. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
9. Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Takeda Pharmaceutical Company Limited ("Takeda") today announced ... of data from a 10-year epidemiology study to ... (U.S.) Food and Drug Administration (FDA), ... Ministry of Health, Labour, and Welfare (MHLW) / ... for pioglitazone containing medicines, including ACTOS (pioglitazone HCl). ...
(Date:8/28/2014)...  In anticipation of the upcoming MEDevice San Diego ... the first time. Industry Overview: Medtech & Life Sciences ... snapshot of San Diego,s critical involvement ... latest employment statistics to current venture capital investment trends, the ... such a vital part of the global medical device ...
(Date:8/28/2014)... 28, 2014 /PRNewswire-iReach/ -- Academy Leadership, an elite leadership ... has published a case study highlighting one ... Course . In September and October 2014, Academy Leadership ... Albuquerque , Indianapolis , Salt Lake ... - http://photos.prnewswire.com/prnh/20140828/140814 Leadership training ...
Breaking Medicine Technology:Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 2Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 3Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 4Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 5Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 6New Infographic Published - Overview of Medtech & Life Sciences Industry in San Diego 2Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 2Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 3Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 4Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 5
... SEATTLE, Aug. 22 Vical Incorporated (Nasdaq:,VICL) announced ... vaccine Phase 2a,clinical trials, using a plasmid DNA ... and manufactured by Vical, reinforced previously,reported Phase 1 ... was safe and well-tolerated, and was effective in ...
... - Alfacell Corporation,(Nasdaq: ACEL ) today announced ... Oncology (2007; Vol. 31, Issue 3: 663-669) reports ... cell types and tumor cell lines. The observed ... cytotoxic effect on cancer cells and,mechanistic synergism with ...
Cached Medicine Technology:Multiple NIH Phase 2 HIV Vaccine Trials Using Vical's Technology Produce Encouraging Results 2Multiple NIH Phase 2 HIV Vaccine Trials Using Vical's Technology Produce Encouraging Results 3Paper in International Journal of Oncology Reports Alfacell's ONCONASE(R) Suppresses Intracellular Oxidative Stress 2Paper in International Journal of Oncology Reports Alfacell's ONCONASE(R) Suppresses Intracellular Oxidative Stress 3
(Date:8/29/2014)... RBS Reputation Management has brought a new ... service is to help those individuals and organizations that are ... Book. The service would push down the ranking of Scam ... fully invisible on Google. , RBS Reputation Management provides ... asked how company can provide guarantee of results with the ...
(Date:8/29/2014)... August 29, 2014 Los Angeles ... offering mini implants to area patients. With this treatment, ... of long-term teeth shifting and loss of appearance. Although ... dental implants , their smaller size allows for ... and easier recovery. Once placed, mini implants can be ...
(Date:8/29/2014)... 2014 "After reading a study that said ... often, I decided that there needed to be a way ... said a concerned inventor from Sikestons, Mo. , The Stand ... It builds endurance and keeps the user from sitting too ... use and producible in design variations, it's ideal for anyone ...
(Date:8/29/2014)... India (PRWEB) August 29, 2014 Ethane ... has recently launched a new service named HTML web ... research based service. Before tailoring the service, Ethane Web ... by other companies. The company has done its best ... impeccable and able to deliver outstanding results to clients. ...
(Date:8/29/2014)... and basic life support (BLS) videos available on ... health guidelines, according to a new study published ... for the Australasian College for Emergency Medicine (ACEM). ... cardiac arrest are known to improve survival for,victims. ... put together the study, which reviewed educational videos ...
Breaking Medicine News(10 mins):Health News:RBS Reputation Management Announces a New Online Reputation Management Service 2Health News:Dental Implants Dentist, Kevin Sands DDS, Is Now Offering Mini Implants 2Health News:Ethane Web Technologies Launches a New Web Design Service 2
... UC Irvine Medical Center recently received a Silver Medal of ... for its role in supporting organ and tissue donation. ... the highest-performing 12-month period between Oct. 1, 2008, and March ... commended in the seven-county Greater Los Angeles area served by ...
... THURSDAY, Dec. 2 (HealthDay News) -- The suicide rate among ... than among civilian women, a new study has found. ... between 2004 and 2007. In the 18-to-34 age group, there ... 33,257,362 nonveterans. That suicide rate amounted to one out ...
... arthritis drug reduces the incidence of non-melanoma skin cancers ... to a study published this week in the ... COX-2 inhibitor celecoxib (brand name Celebrex), which is currently ... acute pain in adults led to a 62 percent ...
... a lawyer, a politician, a professional athlete, an environmentalist or ... some researchers. Still others say the driving force is our ... But a new child-development theory bridges those two models, says ... Holden,s theory holds that the way a child turns out ...
... early in life led to an accumulation of abdominal fat and ... according to new research. Animals exposed to the fine-particulate air ... and higher blood sugar levels than did animals eating the same ... the polluted air for six hours a day, five days a ...
... From microscopy to computer tomography (CT) scans, imaging ... research, but obtaining high-quality images often requires advanced ... a project which launches its preparatory phase today, ... access to state-of-the-art imaging technologies at all levels ...
Cached Medicine News:Health News:UC Irvine Medical Center is recognized for its commitment to organ donation 2Health News:Female Vets Much More Likely to Commit Suicide, Study Finds 2Health News:Widely used arthritis pill protects against skin cancer 2Health News:Widely used arthritis pill protects against skin cancer 3Health News:Beyond nature vs. nurture: Parental guidance boosts child's strengths, shapes development 2Health News:Beyond nature vs. nurture: Parental guidance boosts child's strengths, shapes development 3Health News:Beyond nature vs. nurture: Parental guidance boosts child's strengths, shapes development 4Health News:Polluted air increases obesity risk in young animals 2Health News:Polluted air increases obesity risk in young animals 3Health News:Better imaging from bench to bedside 2
... fast, precise patternless edge for a perfect ... ALE-X1. The latest advance in lens processing ... and functions. High-speed processing, a diamond luster ... precise three-dimensional frame tracing via the automated ...
... mapping software system enhances clinical evaluations with ... corneal maps. The system offers an enlarged ... refractive and keratometric data, and peripheral keratometric ... subclinical keratoconus as well as pre and ...
... Ergonomic, computer-integrated, flexibility, combined with the ... contemporary styling, make the new Topcon ... highly competitive 21st Century practice environments: ... lane fits comfortably in an 8' ...
... Topcon combines the benefits of IMAGEnet Lite, ... a Compaq PC with the Topcon TRC-NW6 ... use color fundus screening package. The system ... software with Topcons Non-Mydriatic retinal camera allowing ...
Medicine Products: